Management of hilar cholangiocarcinoma - Comparison of an American and a Japanese experience

被引:200
|
作者
Tsao, JI
Nimura, Y
Kamiya, J
Hayakawa, N
Kondo, S
Nagino, M
Miyachi, M
Kanai, M
Uesaka, K
Oda, K
Rossi, RL
Braasch, JW
Dugan, JM
机构
[1] Nagoya Univ, Sch Med, Dept Surg 1, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Lahey Clin Med Ctr, Dept Gen Surg, Burlington, MA 01803 USA
[3] Lahey Clin Med Ctr, Dept Surg Pathol, Burlington, MA 01803 USA
[4] Nagoya Univ, Sch Med, Dept Surg Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan
关键词
D O I
10.1097/00000658-200008000-00003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To compare the experience and outcome in the management of hilar cholangiocarcinoma at one American and one Japanese medical center. Summary Background Data Controversies surround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology of such cancers are similar between patients treated in America and in Japan. Methods Records were reviewed of 100 patients treated between 1980 and 1995 at the Lahey Clinic in the United States, and of 155 patients treated between 1977 and 1995 at Nagoya University Hospital in Japan. Selected pathologic slides of resected cancers were exchanged between the two institutions and reviewed for diagnostic concordance. Results In the Lahey cohort, there were 25 resections, 53 cases of surgical exploration with biliary bypass or intubation, and 22 cases of percutaneous transhepatic biliary drainage or endoscopic biliary drainage without surgery. In the Nagoya cohort, the respective figures were 122, 10, and 23. The overall 5-year survival rate of all patients treated (surgical and nonsurgical) during the study periods was 7% in the Lahey cohort and 16% in the Nagoya cohort. The overall 10-year survival rates were 0% and 12%, respectively. In patients who underwent resection with negative margins, the 5- and 10-year survival rates were 43% and 0% for the Lahey cohort and 25% and 18% for the Nagoya cohort. The surgical death rate for patients undergoing resection was 4% for Lahey patients and 8% for Nagoya patients. Of the patients who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and 89% of the Nagoya patients. Histopathologic examination of resected cancers showed that the Nagoya patients had a higher stage of disease than the Lahey patients. Conclusions In both Lahey and Nagoya patients, survival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-negative resections. Combined bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resection rate in the Nagoya cohort.
引用
收藏
页码:166 / 174
页数:9
相关论文
共 50 条
  • [21] Surgical management of resectable hilar cholangiocarcinoma
    Regimbeau, J. -M.
    Fuks, D.
    Chatelain, D.
    Riboulot, M.
    Delcenserie, R.
    Yzet, T.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (6-7): : 620 - 631
  • [22] Liver transplantation for hilar cholangiocarcinoma:: Spanish experience
    Robles, R
    Figueras, J
    Turrión, VS
    Margarit, C
    Moya, A
    Varo, E
    Calleja, J
    Valdivieso, A
    Garcia-Valdelcasas, JC
    López, P
    Gómez, M
    de Vicente, E
    Loinaz, C
    Santoyo, J
    Casanova, D
    Bernardos, A
    Fernández, JA
    Marín, C
    Ramírez, P
    Bueno, FS
    Jaurrieta, E
    Parrilla, P
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1821 - 1822
  • [23] Laparoscopic Management of Hilar Cholangiocarcinoma: a Case Report
    Shailesh Puntambekar
    Vikrant Sharma
    Sanjay Kumar
    Sainath Mitkare
    Geetanjali Joshi
    Hirav Parikh
    Indian Journal of Surgery, 2016, 78 : 57 - 59
  • [24] Portal Vein Resection in Management of Hilar Cholangiocarcinoma
    Hemming, Alan W.
    Mekeel, Kristin
    Khanna, Ajai
    Baquerizo, Angeles
    Kim, Robin D.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 212 (04) : 604 - 613
  • [25] Surgical management of hilar cholangiocarcinoma: Controversies and recommendations
    Jena, Suvendu Sekhar
    Mehta, Naimish N.
    Nundy, Samiran
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2023, 27 (03) : 227 - 240
  • [26] Ongoing Challenges in the Endoscopic Management of Hilar Cholangiocarcinoma
    Aslanian, Harry R.
    Jamidar, Priya A.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (05) : 1255 - 1256
  • [27] Ongoing Challenges in the Endoscopic Management of Hilar Cholangiocarcinoma
    Harry R. Aslanian
    Priya A. Jamidar
    Digestive Diseases and Sciences, 2011, 56 : 1255 - 1256
  • [28] Changing strategies in diagnosis and management of hilar cholangiocarcinoma
    Figueras, J
    Llado, L
    Valls, C
    Serrano, T
    Ramos, E
    Fabregat, J
    Rafecas, A
    Torras, J
    Jaurrieta, E
    LIVER TRANSPLANTATION, 2000, 6 (06) : 786 - 794
  • [29] Laparoscopic Management of Hilar Cholangiocarcinoma: a Case Report
    Puntambekar, Shailesh
    Sharma, Vikrant
    Kumar, Sanjay
    Mitkare, Sainath
    Joshi, Geetanjali
    Parikh, Hirav
    INDIAN JOURNAL OF SURGERY, 2016, 78 (01) : 57 - 59
  • [30] Surgical treatment for hilar cholangiocarcinoma; The University of Tokyo Experience
    Kokudo, Norihiro
    Sakamoto, Yoshihiro
    CANCER SCIENCE, 2018, 109 : 410 - 410